Crinetics Pharmaceuticals presented new data at the ENDO 2025 conference on July 14, 2025.
2 reports, 1 independent
Updated Jul 14
Gone quiet
- Reports
- 2
- Developments
- 1
- Repetition
- 50%
New informationRepeats or wire copies
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
Crinetics Pharmaceuticals presented new data at the ENDO 2025 conference on July 14, 2025.
Who's involved
What this event is mainly aboutKeep exploring
The entities involved
-
Crinetics Pharmaceuticals
company in San Diego, United States
Nothing else this week.
Coverage
Newest first; wire copies grouped- GlobeNewswireCrinetics to Present New Long-Term Data Demonstrating Durable Control of Once-Daily, Oral PALSONIFY™ (Paltusotine) in Acromegaly at ENDO 2025 Data show that PALSONIFY was well tolerated and IGF-1 lev
- Unknown outlet